Investigating adverse drug events in patients taking blood thinners in the emergency department

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the incidence of adverse drug events in patients who are on oral anticoagulation therapy when they present to the emergency department. It focuses on various complications such as traumatic hemorrhage, spontaneous hemorrhage, and thrombosis among patients receiving medications like warfarin and newer anticoagulants. The study will analyze data from patients aged 18 and older admitted to the adult emergency department of Besançon University Hospital over a two-year period. By identifying the frequency and types of adverse events, the study seeks to improve patient safety and management in emergency settings.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥18 years
* Admission to adult emergency department of Besançon University Hospital
* Study period: January 1, 2018 to December 31, 2019
* Current oral anticoagulation therapy with:

  * Acenocoumarol
  * Apixaban
  * Dabigatran
  * Fluindione
  * Rivaroxaban
  * Warfarin

Exclusion Criterion:

\- Discontinuation of anticoagulant therapy for more than 24 hours

Where it's running

• CHU Besançon
  Besançon, France Recruiting

Study contacts

• Study coordinator: Omide TAHERI, MD, PhD
• Email: omide.taheri@gmail.com
• Phone: 03 81 66 70 28

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• A large biobank for acute and emergency medicine

  This study is collecting health information and samples from patients with sudden illnesses in the Emergency Department to see if it can help improve treatments and predict how patients will do.

  Recruiting University Medical Center Groningen · Groningen · NCT04615065

• Simplified Tranexamic Acid Regimen for Trauma with Hemorrhage

  This trial tests a simplified TXA dosing approach to see if it safely helps adults with major trauma and significant bleeding.

  Recruiting at 3 sites Phase 4 Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang and 2 other locations · NCT07869537

• Thromboelastometry to Predict Thrombosis and Survival in Glial Tumor Surgery

  Aimed at people with glial tumors undergoing surgery, the study tests whether thromboelastometry and other blood tests can predict blood-clot risk and survival.

  Recruiting Fundacion Clinic per a la Recerca Biomédica · Barcelona · NCT07813377

• Bleeding control after single-ray amputation: Hemocoll vs Avitene vs bone wax

  This trial tests whether Hemocoll, Avitene, or bone wax better stop bleeding from exposed bone after a planned single-ray amputation in adults.

  Recruiting at 3 sites Adichunchanagiri Institute of Medical Sciences, B G Nagara · Kolār, Karnataka and 2 other locations · NCT07788846

• Optimizing Anticoagulation in Pregnancies With Mechanical Heart Valves

  This study tests whether using low molecular weight heparin with low-dose aspirin during pregnancy is as safe and effective as the standard warfarin-based approach for people with mechanical heart valves.

  Recruiting Mount Sinai Hospital, Canada · Toronto, Ontario · NCT07658989

• Personalized blood-thinner plan for leg artery disease after repair

  A personalized plan using a blood test to tailor antiplatelet therapy is being tested against standard treatment in adults with PAD after a procedure to restore blood flow.

  Recruiting at 2 sites Massachusetts General Hospital · Boston, Massachusetts and 1 other locations · NCT07613840

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.